McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

McKesson's stock appears undervalued, trading at 18 times forward earnings and free cash flow. See why MCK is a Hold.

McKesson MCK has started 2025 on a positive note, with the stock climbing 4% so far in January as investors remain optimistic ...

ROCK HILL — A decade after opening in Rock Hill and growing its workforce, a medical supply distributor is shutting down its Rock Hill operation. McKesson Medical-Surgical Inc. said it is ...

McKesson Medical-Surgical will shut down its Rock Hill, S.C.-based distribution center in the spring, marking the end of its decade-long operation in the area, The Post and Courier reported Dec. 30.

McKesson Corp. closed 6.64% below its 52-week high of $637.51, which the company achieved on August 2nd.

surpassing the Medical sector's loss of 5.3% and the S&P 500's loss of 2.2%. Investors will be eagerly watching for the performance of McKesson in its upcoming earnings disclosure. The company's ...

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...

McKesson (NYSE:MCK – Get Free Report) had its price objective cut by Citigroup from $713.00 to $677.00 in a research note ...

as well as contributions from Prescription Technology Solutions and Medical-Surgical Solutions. Furthermore, McKesson raised its fiscal 2025 adjusted EPS guidance to $32.40 to $33, reinforcing ...

McKesson (MCK) concluded the recent trading session at $585.08, signifying a +0.57% move from its prior day's close.